Address
Lumira Capital Investment Management Inc
530 Lytton Ave
2nd Floor
Palo Alto, CA 94301
United States
Lumira Capital Investment Management Inc
1550 Metcalfe Street
Suite 502
Montreal QC H3A 1X6
Canada
Website
Industry
Business classification
VCID: 42417
Profile
Corporate information
Official name
Lumira Capital Investment Management Inc.
Also known as
Lumira Ventures
Registration country
Official name
Lumira Capital Investment Management Inc.
Also known as
Lumira Ventures
Registration country
Investment activity status
Active investor
Company type
Canadian healthcare and life sciences venture capital firm.Team
![[node:title] photo](/sites/default/files/styles/icon/public/default_images/icon-person.png?itok=8SSzz6Wf "[node:title] photo"){kind=icon}
Investments
Investment preferences
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
BaroNova Inc Developer of non-surgical devices to induce weight loss |
United States | 15 Feb 2013 23 Nov 2015 |
Series D Follow-on investment. Round participant. Active |
|
|
|
DC Devices Inc Developer of medical equipment used in the treatment of heart failure |
United States | 18 Mar 2013 | Venture Initial investment. Round participant. Active |
|
|
|
Argos Therapeutics Inc |
United States | 1 Apr 2008 1 Apr 2012 |
Series D Follow-on investment. Round participant. Active |
|
|
|
Avalon Pharmaceuticals Inc Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Corus Pharma Inc A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Pharmasset Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
Replidyne Inc Biopharmaceutical company, engages in discovering, developing, in-licensing, and commercializing anti-infective products. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
DepoMed Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Resonant Medical Inc |
Canada | N/A Initial investment. Round participant. Active |
||
|
|
Alexza Pharmaceuticals Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Guava Technologies Inc A biotechnology company providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Triangle Pharmaceuticals Inc Anti-viral and oncology licensing company. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Ception Therapeutics Inc Ception Therapeutics, Inc. is an emerging biopharmaceutical company. |
United States | N/A Active |
||
|
|
ISTA Pharmaceuticals Inc Specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
NephroGenex Inc NephroGenex is developing a product to slow the progression of diabetic nephropathy. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Alveolus Inc |
United States | N/A Active |
||
|
|
Spinal Kinetics Inc |
United States | N/A Initial investment. Round participant. Active |